These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4714145)

  • 1. Function of official compendia.
    Banes D
    J Pharm Sci; 1973 Jul; 62(7):VI. PubMed ID: 4714145
    [No Abstract]   [Full Text] [Related]  

  • 2. The official compendia.
    Macek TJ
    Pharmacology; 1972; 8(1):204-6. PubMed ID: 4644650
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of dissolution standards.
    Leeson LJ
    J Pharm Sci; 1973 Sep; 62(9):VI. PubMed ID: 4743126
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro solubility studies of commercially available pharmaceutical products.
    Muti H; Papaioannou G; Choulis NH
    Pharmazie; 1983 Nov; 38(11):779. PubMed ID: 6669602
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro drug release rate as a standard requirement.
    Láng B
    Pharmazie; 1971 Nov; 26(11):661-4. PubMed ID: 5154319
    [No Abstract]   [Full Text] [Related]  

  • 6. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control and compliance testing.
    Bergen JV
    J Pharm Sci; 1973 Sep; 62(9):VI. PubMed ID: 4743125
    [No Abstract]   [Full Text] [Related]  

  • 8. USP standards for dissolution and bioavailability.
    Grady LT
    Am J Hosp Pharm; 1982 Sep; 39(9):1546-8. PubMed ID: 7137198
    [No Abstract]   [Full Text] [Related]  

  • 9. [Official inspections of a pharmaceutical plant during the registration of new products].
    De Martiis F; Fontani F; Zanotti-Gerosa A
    Boll Chim Farm; 1982 Jul; 121(7):319-27. PubMed ID: 7150440
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacopoeias and official quality standards for pharmaceutical evaluation in the Hungarian People's Republic].
    Laszlovszky J
    Pharmazie; 1981 Nov; 36(11):778-9. PubMed ID: 7323127
    [No Abstract]   [Full Text] [Related]  

  • 11. Conductimetric determination of phenylpropanolamine HCl, ranitidine HCl, hyoscyamine HBr and betaine HCl in their pure state and pharmaceutical preparations.
    Issa YM; Youssef AF; Mutair AA
    Farmaco; 2005; 60(6-7):541-6. PubMed ID: 15890349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
    Claude JR; Claude N
    Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems of drug testing].
    Zbinden G
    Schweiz Rundsch Med Prax; 1970 Jul; 59(28):1019-20. PubMed ID: 5512822
    [No Abstract]   [Full Text] [Related]  

  • 14. Biopharmaceutics and drug standards.
    Feldmann EG
    Am J Hosp Pharm; 1968 Mar; 25(3):111-9. PubMed ID: 5658858
    [No Abstract]   [Full Text] [Related]  

  • 15. Purpose and methodology in clinical trials on new drugs.
    Collins IS; Thorpe PC
    N Z Med J; 1970 Mar; 71(454):148-51. PubMed ID: 4910417
    [No Abstract]   [Full Text] [Related]  

  • 16. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology.
    Jenkinson DH; Barnard EA; Hoyer D; Humphrey PP; Leff P; Shankley NP
    Pharmacol Rev; 1995 Jun; 47(2):255-66. PubMed ID: 7568328
    [No Abstract]   [Full Text] [Related]  

  • 17. Biopharmaceutic equivalency and the role of the Food & Drug Administration.
    Hodges RM
    Am J Hosp Pharm; 1968 Mar; 25(3):121-7. PubMed ID: 5658859
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems of drug safety].
    Liljestrand A
    Nord Med; 1967 Nov; 78(47):1535-9. PubMed ID: 6075272
    [No Abstract]   [Full Text] [Related]  

  • 19. Parenteral suspensions.
    Nash RA
    Bull Parenter Drug Assoc; 1972; 26(2):91-4. PubMed ID: 5012208
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of dissolution profile in stability tests].
    Lengyel M; Dredán J; Shafir G; Klebovich I; Antal I
    Acta Pharm Hung; 2007; 77(2):132-41. PubMed ID: 17933273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.